Try our Advanced Search for more refined results
Life Sciences - March, 2007
120 articles
- Novartis Stops Drug Marketing Amid Safety Concerns
- California Pharmas Spar Over Chinese Licensing
- Plaintiff Can't Cherry-Pick Court, Judges Rule
- Clarity Needed For Scope Of Waiver As To Litigation Counsel
- E.U. Targets Boehringer For Misuse Of Patent System
- Abott Sues Teva, Sandoz, Ranbaxy Over Omnicef
- Federal Circuit Backs Teva In Patent Challenge
- Jury Makes Diomed $12.5M Richer
- Schering Takes Aim At Glenmark Over Zetia
- Pa. Health Insurers' Merger Stirs Antitrust Concerns
- Stryker Unit Wins Summary Judgment In Patent Case
- Eckerd Prevails In Appeal Of FLSA Case
- Cooley Godward Kronish
- Merck Wins Appeal To Prohibit Generic Eye Drug
- Merck's Fosamax Patent Reinstated In E.U.
- Settlements With Payments To Generics Increase: FTC
- Tyco Files Suit Over Generic Sleep Aid
- Firm Faces Trial Over Fen-Phen Settlement
- FDA Moves To Improve In Wake Of Safety Scrutiny
- FDA Banned From Approving More Generic Norvasc
- Merck KGaA Unit Files Patent Suit Against Sepracor
- Hemosol Granted Fourth Stay Extension
- Critics Say Biologics Bill Doesn't Protect Innovators
- Illinois Jury Hands Merck A Win
- BioSafe Creditors Bid For Chapter 11 Trustee
- Italy Orders Merck To Grant Free Licenses
- NYC Withdraws $3.75M Claim Against Curative
- Bayer, Novartis Settle MS Drug Dispute For $200M
- Pfizer Fills Shelves With Generic Norvasc
- Biovail Fires Kasowitz Benson In Document Debacle
- Witnesses Voice Support For Biologic Pathway
- Eisai Targeted Again Over Aciphex Patent
- Mylan Races To Launch Generic Norvasc
- FTC Taps Cephalon Again Over Provigil Deal
- Appeals Court Deals Blow To Pfizer
- Pharmaceutical Holdings Admits Infringement In Deal
- Permanent Injunction Ends Topamax Patent Fight
- Court Dismisses Patent Suit Against Stryker
- Scope Of Waiver Needs Clarification, Bright-Line Test
- Amgen Asks High Court To Hear Landmark Case
- Shire Ensnares Another Generic Co. Over Adderall
- Holland Snags Former Illinois AG Senior Counsel
- House Panel Shelves Debate On "Say And Pay" Bill
- Oxfam Slams Abbott Over Thailand Standoff
- Sidley Austin Nets Antitrust Litigator
- Takeda Wins $16.8M In Fees For Misconduct
- McDermott Puts IP Group Under New Leadership
- Barr Sued Over Plan For Schizophrenia Drug
- FDA Proposes Tougher Guidelines For Advisers
- Pfizer Whistleblower Challenges Claim Dismissal
- Cardinal Health Sued Over Tissue Implant Patents
- Interest Group Has No Standing In Medicare Suit
- Medtronic Wins Appeal Over Spinal Technology
- Pfizer Wins Celebrex Challenge
- Court Upholds FDA Ban On Diet Pills
- High Court Seeks U.S. Opinion On Tamoxifen Case
- Milberg Weiss Class Action Bid Denied
- Alexion's Soliris Blood Drug Draws New Patent Cases
- Medtronic Sues Cordis In New Stent Dispute
- Hospital Settles Medicare Allegations For $7.5M
- D.C. Court Rebuffs Challenge To Pharmaceutical Statute
- CalPERS Lists Cos. With Worst Corporate Governance
- Appeals Court Overturns Contraception Ruling
- DNA Manufacturer Sued For Patent Infringement
- Pepper Hamilton Snatches Attorney From DOJ
- Angiotech Triumphs In Stent Patent Appeal
- Germany Tops International Trademark List
- Wyeth Sues Fourth Drug Maker Over Generic Effexor
- Zonare Lobs Counterclaims In Ultrasound Patent Spat
- Judge Orders Amerigroup To Cough Up $334M
- Glaxo Receives France's First Predatory Pricing Fine
- Illumina Infringed Gene Detection Patents: Jury
- Abbott Strikes Back In Thailand Drug Feud
- Judge Strikes Down Nellson Settlement
- Lessons From The Genentech V. Insmed Trial
- J&J Subpoenaed Over Topamax, Risperdal, Natrecor
- Braintree Labs Hit With Antitrust Suit Over MiraLax
- Judge Tosses Counterclaims In Eye Surgery Spat
- Toronto Snapshot: Borden Ladner Gervais LLP
- FDA Issues New Anemia Drug Warnings
- FTC Follows Through On Express Scripts Query
- HIPAA Violation May Form Basis for Lawsuit
- Toronto Snapshot: Blake, Cassels & Graydon LLP
- Pepper Hamilton Strengthens IP Group
- Top Biotech IP Attorney Joins Holland & Knight
- Jury To Decide Validity Of Iridex Patent
- Jury Rules Vioxx Caused Heart Attack, Awards $47.5M
- FDA Probes Off-Label Uses Of Drug-Coated Stents
- Federal Circuit Delivers Blow To Abbott
- Express Scripts Maintains Antitrust OK Within Reach
- Suit Comes Back To Haunt Medtronic
- Generic Pathway For Biologics Weighed At Hearing
- DOJ, SEC Reach Deal In Drug Maker's Insider-Trading
- Toronto Snapshot: Miller Thomson LLP
- D.C. Court Reinstates PBM Disclosure Laws
- Express Scripts' Sweetened Bid Turns Sour
- Antitrust Suit: Purdue Pharma Tricked PTO
- Judge Allows $8.7M Ruling In Vioxx Case To Stand
- Judge Lifts Injunction On Drug Maker
- Genentech, Tercica, Insmed Settle Patent Suit
- EEOC Smacks Walgreens With Race Bias Suit
- Spine Implant Suit Disappears After A Day
- Gobbledygook At The Supreme Court
- House Committee Probes Drug Makers
- Gore-Tex Maker Sued Over Surgical Material
- Solvay Loses False Advertising, Trademark Case
- Novartis Refuses To Yank Gleevec Lawsuit
- Judge Declines To Overturn Vioxx Jury Verdict
- Elan Targeted In Off-Label Marketing Probe
- QLT, Novartis Settle Patent Dispute With Hospitals
- The EEOC's New Treatment Of Health Care Workers
- Biovail Abandons Wellbutrin Litigation
- Sandoz Sued Over Schizophrenia Drug Patent
- Roche Suit Over Diabetes Test Strips Crumbles
- U.K. Court Greenlights Pfizer Drug Supply Deal
- New Jersey Jury Splits In Vioxx Cases
- Russia Launches Probe Of Glaxo Vaccine Trials
- Express Scripts Seeks New Vote Delay
- Third Wave Files Antitrust Claim Over HPV Test
- Software Maker Sues Boston Scientific For Piracy